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Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
Toxoplasma gondii is capable of actively invading almost any mammalian cell type
including phagocytes. Early events in phagocytic cells such as dendritic cells are
not only key to establishing parasite infection, but conversely play a pivotal role
in initiating host immunity. It is now recognized that in addition to changes in
canonical immune markers and mediators, alteration in metabolism occurs upon
activation of phagocytic cells. These metabolic changes are important for supporting
the developing immune response, but can affect the availability of nutrients for
intracellular pathogens including T. gondii. However, the interaction of T. gondii
with these cells and particularly how infection changes their metabolism has not
been extensively investigated. Herein, we use a multi-omics approach comprising
transcriptomics and metabolomics validated with functional assays to better understand
early events in these cells following infection. Analysis of the transcriptome of
T. gondii infected bone marrow derived dendritic cells (BMDCs) revealed significant
alterations in transcripts associated with cellular metabolism, activation of T cells,
inflammation mediated chemokine and cytokine signaling pathways. Multivariant analysis
of metabolomic data sets acquired through non-targeted liquid chromatography
mass spectroscopy (LCMS) identified metabolites associated with glycolysis, the
TCA cycle, oxidative phosphorylation and arginine metabolism as major discriminants
between control uninfected and T. gondii infected cells. Consistent with these
observations, glucose uptake and lactate dehydrogenase activity were upregulated
in T. gondii infected BMDC cultures compared with control BMDCs. Conversely,
BMDC mitochondrial membrane potential was reduced in T. gondii-infected cells
relative to mitochondria of control BMDCs. These changes to energy metabolism,
similar to what has been described following LPS stimulation of BMDCs and
macrophages are often termed the Warburg effect. This metabolic reprogramming
of cells has been suggested to be an important adaption that provides energy and
precursors to facilitate phagocytosis, antigen processing and cytokine production. Other
changes to BMDC metabolism are evident following T. gondii infection and include
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upregulation of arginine degradation concomitant with increased arginase-1 activity and
ornithine and proline production. As T. gondii is an arginine auxotroph the resultant
reduced cellular arginine levels are likely to curtail parasite multiplication. These results
highlight the complex interplay of BMDCs and parasite metabolism within the developing
immune response and the consequences for adaptive immunity and pathogen clearance.
Keywords: dendritic cells, immunometabolism, Toxoplasma gondii, LPS stimulation, Warburg effect, arginine
metabolism, multi-omics
INTRODUCTION
Toxoplasma gondii is an obligate intracellular parasite that
actively invades mammalian cells where it multiplies rapidly
before actively egressing to infect other cells. It can infect almost
any mammalian cell type including phagocytes such as dendritic
cells (Dubey, 1998; Sibley, 2011). As an intracellular parasite
T. gondii has evolved a close relationship with mammalian host
cells and is known to rely on them for a number of nutrients
(Silva et al., 2002; Dubey, 2004; Sibley et al., 2012). Conversely
the host has evolved immune mechanisms that directly kill T.
gondii or restrict the availability of certain nutrients and thus
control the growth of the parasite (Denkers, 2010; Pifer and
Yarovinsky, 2011). In addition, a considerable body of literature
now recognizes that activation of phagocytes during infection
not only results in alteration of canonical immune markers
and mediators, but causes fundamental changes to metabolism
with potential to direct the quality of the immune response.
Therefore, the nature and combination of these early events
in these cells may play a pivotal role in establishing T. gondii
infection, initiating host immunity and determining the outcome
of acute toxoplasmosis.
An important immune-mediated metabolic change known to
occur in phagocytes is energy metabolism which is responsible
for the production of ATP used in all energy dependent processes
within cells (Hinkle and McCarty, 1978). In the most simplistic
form, ATP can be formed through glycolysis in the cytosol
and yields two ATP molecules. Pyruvate is made as a by-
product of this process and in anaerobic conditions is fermented
to lactate. In aerobic conditions, pyruvate can be fed into
the TCA cycle located within the mitochondria to produce
thirty-six ATP molecules. This is dependent on a functioning
electron transport chain (ETC) and this entire process is termed,
oxidative phosphorylation. Unsurprisingly, ∼95% of a naïve
immune cells’ energy is generated via oxidative phosphorylation
under normoxic conditions. However, it has been shown under
certain circumstances, immune cells favor ATP production by
glycolysis, even in an normoxic environment. This is known as
aerobic glycolysis or the “Warburg effect” (Warburg et al., 1958;
Reviewed by Palsson-McDermott and O’Neill, 2013). Changes
in the TCA cycle can also affect a large variety of biosynthetic
processes for which it provides essential intermediates. Thus,
modulation of energy metabolism has proximal and distal
functional benefits for immune cells including macrophages
and dendritic cells as it provides the precursors for protein
manufacture and fatty acid synthesis required for cytokine
production and membrane remodeling.
The vast majority of work described thus far in the literature
has used LPS, IFN-γ, or IL-4 as surrogate immune activators
rather than live infections. Within the literature, metabolic
reprogramming of LPS (innate activation), LPS + IFN-γ
(classical activation) or IL-4 (alternative activation) treated
macrophages has been well-documented (Pearce et al., 2013;
Murray et al., 2014). Generally, in the literature, LPS stimulation
is associated with numerous metabolic changes culminating in
a shift from oxidative phosphorylation to aerobic glycolysis
(“Warburg effect”). In contrast, IL-4 stimulation is associated
with augmented oxidative phosphorylation and ATP production
(Newsholme et al., 1986; O’Neill and Hardie, 2013; Jha et al.,
2015). BMDCs are known to be responsive to many of the same
mediators as macrophages and depending on their activation
status, share a number of functions (O’Neill and Pearce, 2016).
As the main antigen presenting cells in the body, DCs have
the unique ability to initiate T cell activation by delivering
antigen from the periphery to secondary lymphoid organs. In
addition, DCs that encounter pathogens generate cytokines and
chemokines attracting or activating other cell types at the site
of infection (Austyn, 2016). In vitro granulcoyte (GM-CSF)
differentiated BMDCs have been likened to in vivo murine iDCs
(Guilliams et al., 2016) and studies have shown that stimulation
with LPS induces increased glucose uptake, aerobic glycolysis
and augmentation of the pentose phosphate pathway while
suppressing oxidative phosphorylation (encompassing both the
TCA and ETC) (Jantsch et al., 2008; Krawczyk et al., 2010). This
leads to “enzymatic breaks” in the TCA cycle and intermediate
accumulation which is used for other immune functions (Rubic
et al., 2008; Infantino et al., 2011; Tannahill et al., 2013;
Everts et al., 2014). In addition, a dichotomy exists between
LPS stimulated and IL-4 treated BMDCs in terms of arginine
metabolism. LPS stimulation of BMDCs, like macrophages, was
found to promote increased arginine metabolism as determined
by an increase in both inducible nitric oxide synthase (iNOS) and
the production of citrulline and arginosuccinate. In contrast, IL-4
treatment induces the conversion of arginine into ornithine and
proline via arginase (Corraliza et al., 1995; Munder, 1997; Van
den Bossche et al., 2012; Reviewed by Thwe and Amiel, 2018).
Host cells recognize T. gondii through a number of pathogen
associated molecular patterns (PAMPS) that are known to
activate toll-like receptors (TLR2, 4 and 11) in mice and in
theory have the ability to induce similar changes as seen with LPS
stimulation of phagocytes (Butcher et al., 2005) Investigating how
host cells reprogram their metabolism in response to intracellular
pathogens is complex. Firstly, it is challenging to separate host
from pathogen metabolism in many assays. Secondly, these
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pathogens have a number of secretory molecules that can also
alter host cell metabolism for their own benefit. To overcome
this, the transcripts can be aligned to the mouse genome and
although there is a degree of similarity between host and parasite
enzymes at the amino acid level, they are very different at the
DNA level and can therefore be identified unambiguously. This
strategy has been used previously for the study of a variety of
different intracellular and extracellular pathogens (Blader et al.,
2001; Chaussabel et al., 2003).
Herein, we used a multi-omics approach comprising
transcriptomics and metabolomics on murine GM-CSF
differentiated dendritic cells which we validated with functional
studies to better understand how T. gondii metabolically
reprograms dendritic cell metabolism in vitro and how this
compares with the effect of LPS. We show that some observed
changes are consistent with parasite evolved mechanisms to
subvert the host immune response, while other are consistent
with host derived mechanisms to control parasite dissemination.
MATERIALS AND METHODS
Mice
Eight to ten-week-old, male BALB/c mice were bred and
maintained in house at the Strathclyde Institute of Pharmacy
and Biomedical Sciences, Glasgow, UK. All animal procedures
including Schedule 1 conformed to guidelines from The Home
Office of the UK Government.
Generation of Murine Dendritic Cells
Bone marrow derived dendritic cells were cultured by flushing
femurs and tibia of 8 to 10-week-old BALB/c mice with
RPMI 1640 supplemented with 10% heat inactivated FCS, 10%
Granulocyte-monocyte colony stimulating factor (conditioned
from the supernatant of x63 cells), 5mM L-glutamine, 100 U/ml
penicillin, 100 µg/ ml streptomycin and incubated at 37
◦
C for
7 days. After this time, adherent and semi-adherent cells were
harvested and then seeded into either 24 well plates (1× 106 cells/
ml) or 96 wells plates (1× 105 cells/100 ul).
Maintenance of Transfected T. gondii
Prugniaud Strain
Tachyzoites were routinely maintained in confluent human
foreskin fibroblasts (HFFs) grown in DMEM complete medium
comprising of 10% fetal calf serum, 5mM L-glutamine, 100 U/ml
penicillin, 100 µg/ ml streptomycin and 50 U/ml amphotericin B
at 37
◦
C in 5% CO2.
Dendritic Cell Infection With T. gondii
For infection, 1 × 106 BMDCs were seeded into 24 well-plates
in complete RPMI 1640 medium. The cells were infected with
1 × 106 type II Prugniaud strain T. gondii tachyzoites. In
some experiments, dendritic cells were also treated with E.coli
LPS (1 µl/ml).
Measuring Nitric Oxide in Cell Supernatant
Cell supernatant nitric oxide levels were determined by Griess
assay. Cell supernatant or standards were added in equal volumes
with Griess Reagent (1:1 ratio of 2% sulphanilamide in 5%
H3PO4 and 0.2% Napthylene diamine HCL in ddH2O) in a 96
well-plate and incubated in the dark for 10min. Absorbance was
read at 540 nm on a Spectromax 190 plate reader and serum
nitrite concentrations were calculated against a standard curve.
Measurement of Arginase-1 Expression
Arginase activity wasmeasured using an assay based on a reaction
with α-isonitrosopropiophenon (ISPF) as described previously
(Al-Mutairi et al., 2010). Briefly, BMDCs were grown on 24-well
plates, exposed to agonist as appropriate and harvested in 50 ul
lysis buffer (50mM Tris-HCL, 10mM MnCl2, 0.1% Triton X-
100, 5 ug/ml pepstatin A, 5 ug/ml aprotinin, and 5 ug/ml antipain
hydrochloride, pH 7.4). Arginine hydrolysis was carried out by
incubating cell lyates with 25 ul of 0.5M L-arginine (pH 9.7) at
37
◦
C for 60min. The reaction was terminated by adding 400 ul
of an acid solution (H2SO4, H3PO4, and H2O in a ratio of 1:3:7
and 25 ul of 9% solution of ISPF). Samples along with known urea
standards were incubated at 95
◦
C for 45min and then allowed to
cool for 10min in the dark. Aliquots were added to wells of a 96
well-plate and absorbance read at 540 nm on a Spectromax 190
plate reader.
Flow Cytometry
Cells were harvested for staining and incubated with Fc-
block for 10min at room temperature. Cells were stained for
1 h at 4
◦
C with CD11c—PE or FITC, CD40—APC, CD80—
FITC, CD86—APC-cy7 (BD bioscience). Cells were fixed
using Fix & Perm (Life Technologies) following manufacturer’s
instructions. Intracellular staining was performed using iNOS—
PE (ebioscience). For glucose uptake assays, 50 ul fluorescent
glucose analog (2-NBDG-FITC) was added to the cells 120min
before harvest. CFSE labeled T. gondii was used for uptake
assays. A total of 30, 000–50, 000 events per sample was acquired
on a BD FASCanto and data analysis was carried out using
FlowJo software.
Measurement of Lactate Dehydrogenase
Activity
BMDCs were co-cultured or stimulated with LPS as previously
described before the cells were harvested and lysed. Intracellular
lactate dehydrogenase activity was measured following
manufacturer’s instructions. The lactate dehydrogenase activity
assay kit was supplied by Sigma-Aldrich (Catlog number:
MAK066). This kit reduces NAD to NADH, which is specifically
detected as a colorimetric assay.
Preparation of Extracts for LCMS
BMDCs were co-cultured with T. gondii or stimulated with LPS
for 24 h before metabolite extraction. The extraction process
involved cooling the cells for 10min on ice to suppress further
metabolic changes before the removal of the supernatant. The
cells were washed twice with ice cold PBS (Thermo Fisher, UK)
and an extraction mixture of cold methanol (VWR Chemicals,
Leicestershire, UK), ddH20 and chloroform (VWRChemicals) in
a 60: 20: 60 ratio was added. The cells were scraped thoroughly,
and the extracts were shaken at 1,400 rpm for 60min at 4◦C in
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a thermomixer. After centrifugation at 12,000 × g for 15min at
4◦C, the supernatant from these samples were then transferred
to LCMS vials (Sigma-Aldrich/ Merck, Germany) and stored
at−80◦C.
LCMS was carried out by Glasgow Polyomics, University of
Glasgow, UK. Separation was performed using a zwitterionic
ZIC pHILIC column (150 × 4.6mm; 5 uM, Merck) on a
Dionex Ultimate 3000 RSLC system (Thermo Fisher) with an
injection volume of 10 ul and a flow rate of 0.3 ml/ min. The
column was eluted on a gradient of mobile phase A, 20mM
ammonium carbonate pH 9.2 and mobile phase B, acetonitrile
(ACN). Mass detection was carried out using an Orbitrap
QExactive mass spectrometer (Thermo Fisher) operated in
polarity switching mode.
Data Processing
Raw data files of metabolite standard solutions were processed
at the University of Strathclyde using ToxID 2.1 (Thermo
Fisher Scientific Inc., Hemel Hempstead, UK) with ± 3 ppm
(parts per million) mass accuracy of both ESI positive and
negative modes. After checking the appearance of the ion
chromatograms with respect to peak shape, the standards
were used to calibrate IDEOM v19. Raw files of the sample
metabolites from the LCMS were processed by converting
the data files to a universally accepted mxXML open file
format using msConvert (ProteoWizard). Chromatograms were
extracted using a detection algorithm from XCMS and stored in
PeakMLfiles before aligning replicate peaks and combining them
using mzMatch.R. A CSV file was generated after noise filtering
and gap filling (quality control), which was then imported into
IDEOM v19 for metabolite identification (Creek et al., 2012).
This was based on accurate mass (± 3 ppm) and matching the
observed retention time to a database of predicted retention
times, based on physicochemical properties of metabolites
calculated from their chemical structure. Chromatograms for
individual metabolites were examined manually to check peak
shape. All metabolites assigned an arbitrary confidence level ≤6
by IDEOM, representing a predicted retention time match of
<35% (± 21 s), were rejected. Lipids and peptides were also
excluded from the putatively identified metabolites in IDEOM.
Confirmation of Metabolite Identity
The identity of the metabolites was confirmed by accurate mass
and matching the sample retention time to that of an authentic
standard (± 0.3min). The confirmed metabolites correspond to
the metabolic standards initiative (MSI) level 1 whilst metabolites
putatively identified by accurate mass and predicted retention
time correspond to MSI level 2.
RNA-Sequencing
BMDCs activated with LPS or co-cultured with T. gondii were
harvested after 6 h and the mRNA was extracted from the cell
pellets using the RNeasy mini kit (Qiagen) with QIAshredder
column (Qiagen, Manchester, UK). An agilent 2100 bio analyser
was used to assess the quality of the RNA extracted (Agilent,
Cheshire, UK). RNA samples with a concentration >20 ng/µl
and RIN >8 was sent to be processed for RNA-seq using the
Illuminia sequencing technology at Eurofins GATC Biotech,
Konstanz, Germany. Bowtie was used to generate the reference
alignments transcriptome alignments to align the RNA-seq reads
to the reference transcriptome (mouse). Potential exon-exon
splice junctions of the initial alignment were identified by
Tophat. Cuﬄinks (part of CummeRbund software) was then used
to identify and quantify the transcripts from a pre-processed
RNA-seq alignment assembly. After this, Cuffmerge merges
the pieces of the transcripts into full length transcripts and
annotated the transcripts. Finally, merged transcripts from two
(or more) samples were compared using Cuffdiff to determine
the differential expression at transcript level. This includes giving
a measure of significance (Benjamini-Hochberg correction)
between the samples using fragment per kilobase per million
mapped reads (FPKM) for each transcript. For interpretation
purposes, each transcript is shown as Log2 (fold change)
compared to the control and illustrated in a heat map. The quality
of the data obtained is outlined in the Supplementary data.
Mitochondrial Staining
BMDCs were plated at 1 × 105 into a Lab-tek chambered
1.0 borosilicate coverglass system (Catalog no: 155411;
Thermo Scientific). Briefly, the cells were washed with PBS
before the addition of Tetramethylrhodamine, Methyl Ester,
Perchlorate (TMRM) and Mitotracker Green (Thermo fisher).
All dyes were added at a final concentration of 100 nM
each for 45min in complete phenol red free RPMI. Cells
were washed with PBS to remove extracellular Mitotracker
Green, but TMRM was retained in the imaging PBS (as it
is freely permeable and equilibrates across membranes in a
Nernstian-manner). The cells were placed in a 37◦C stage-
top chamber (OKO Labs H301-mini) for imaging. BMDCs
were imaged on a Nikon Eclipse Ti inverted epifluorescence
microscope with a 100x 1.3 NA oil immersion objective lens
plus a 1.5x internal microscope adapter lens (Nikon) and
Flash 4.0 CMOS camera (Hamamatsu). The samples were
imaged with an excitation light of 470nm (Mitotracker Green)
and 550 nm (TMRM) (pE4000 LED light source, CoolLED).
Camera recording and excitation light controlled by Win Fluor
v3.9.1 software (John Dempster, University of Strathclyde).
Image analysis was performed using FIJI (Schindelin et al.,
2012). All MitoTracker Green and TMRM images were set
to the same intensity scale and then converted from 16-
to 8-bit to allow application of a mean intensity threshold.
Regions of interest were drawn manually around each cell
periphery and the threshold set such that only the mitochondria
were selected, equally for each pair of images. The “Multi
Measure” function of FIJI was then used to measure the mean
fluorescence intensity within each cell for both MitoTracker
Green and TMRM and the ratio of (mean TMRM)/(mean
MitoTracker Green) taken as a measure of relative mitochondrial
membrane potential (membrane-potential-dependent
fluorophore/membrane-potential-independent fluorophore).
Cytokine Bead Array (CBA)
Concentrations of different cytokines were determined
in the supernatant of naïve BMDCs, LPS stimulated
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BMDCs and BMDCs co-cultured with T. gondii using the
LegendplexTM Mouse Inflammation Panel (Cat no; 740150;
Biolegend, UK). The assay was carried out as per the
manufacturer’s instructions.
Data Analysis
Prior to Principal component analysis (PCA) and Orthogonal
partial least squares discriminant analysis (OPLS-DA), the
data were mean-centered and Pareto (Par) scaled. PCA,
OPLS, and VIP (Variable importance in the projection) plots
were performed using SIMCA-P13 (Umetrics, Sweden). For
metabolomics data, a non-parametric one-tailed Mann Whitney
test was used for all individual putatively identified metabolites.
p < 0.05 was considered significant. Graph Pad prism 7 was
used for plotting the graphs and heat maps. Heat-maps show
the fold change in each metabolite compared to the control.
All functional data was performed by a one-way ANOVA with
either a Bonferroni or Dunnett post-test unless otherwise stated.
Throughout this thesis, ∗p< 0.05, ∗∗p< 0.01, and ∗∗∗p< 0.001.
RESULTS
T. gondii Actively Invades BMDCs
CFSE labeled T. gondii parasites (MOI 1:1) were co-cultured with
BMDCs to establish the extent these parasites were internalized.
Flow cytometry was used to identify CFSE labeled T. gondii
in CD11c+ cells. Paraformaldehyde fixed parasites were used
as a comparator to determine the potential of BMDCs to
internalize dead parasites. CFSE labeled live T. gondii were
found in approximately 80% of CD11c+ cells while PFA fixed T.
gondii were found in significantly fewer BMDCs (approximately
40%) (Figure 1).
T. gondii Augments CD40, CD80 and CD86
Transcript and Protein Levels, but Down
Regulates MHC Transcripts
CD80 and CD86 work in concert with MHCI and MHCII
to activate T cells. The activation profiles of BMDCs co-
cultured with T. gondii or stimulated with LPS were determined
by flow cytometry and transcriptomics. In comparison to
naïve BMDCs, those co-cultured with T. gondii or stimulated
with LPS had significantly increased CD40 and CD80 protein
levels (Figures 2B,C). In contrast CD86 was only seen to be
upregulated in BMDCs co-cultured with T. gondii (Figure 2C).
Many of these changes also were evident in the transcriptomic
data including cd80 and cd86 mRNA transcripts which
were upregulated in BMDCs co-cultured with T. gondii.
Similarly, transcripts for cd40, cd80, and cd86 were significantly
upregulated in LPS stimulated BMDCs. (Figure 2A). A number
of transcripts for MHC class I and II molecules were significantly
downregulated in BMDCs co-cultured with T. gondii. In
contrast, transcripts for MHC class I and II molecules were
generally significantly upregulated in BMDCs stimulated with
LPS compared with control cells (Figure 2A).
FIGURE 1 | T. gondii actively invades BMDCs. Bone marrow derived DCs
were co-cultured with CFSE labeled T. gondii tachyzoites (MOI 1:1). After 6 h,
cells were analyzed by flow cytometry to determine CFSE parasite uptake.
Results are representative of three independent experiments and show mean
± SEM (n = 3). A one-way ANOVA was performed with a Bonferroni post-test
to determine significance (P < 0.01) where ***p < 0.001.
T. gondii Influences the Cytokine Profile of
BMDCs at Both the mRNA and Protein
Level
Cytokine production by BMDCs co-cultured with T. gondii or
stimulated with LPS were measured in culture supernatants
by cytometric bead array (CBA) and compared with the
transcriptomic data to validate the RNA sequencing process.
The cytokine protein levels of IL-1α, IL-12p70, IL-6, and
IL-10 were significantly increased in T. gondii co-cultured
BMDCs. This was largely consistent with the transcriptomic
data which found significant upregulation of Il1a, Il12a, and Il6
transcripts. Similarly, LPS significantly increased the mRNA and
protein levels compared to naïve BMDCs, for of all cytokines
measured (Figure 3).
Dendritic Cells Co-cultured With T. gondii
or Stimulated With LPS Undergo Distinct
but Overlapping Transcript and Metabolic
Changes
Principal component analysis (PCA) demonstrated distinct
separation between T. gondii infected and naïve BMDCs
(Figure 4). Furthermore, Orthogonal partial least squares
discriminant analysis (OPLS-DA) was used to generate a ranked
table of variable importance in projection (VIP) table for
metabolites and transcripts (Supplementary Tables 1–4). The
transcripts were aligned to a Mus musculus reference gene
ensuring there is no T. gondii specific transcripts and all raw
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FIGURE 2 | T. gondii alters the cellular activation transcript and marker expression of BMDCs. Bone marrow derived DCs were co-cultured with T. gondii tachyzoites
(MOI 1:1) or stimulated with LPS as indicated for 6 or 24 h. After 6 h, (A) mRNA was subsequently extracted and then quantified using RNA-seq. Data shows the log2
(fold change) as normalized to unstimulated controls. Red indicates an increase in mRNA expression, green indicates a decrease in transcript expression and gray
shows no changes from the control cells. In addition, cells were analyzed by flow cytometry after 24 h to determine the proportion of CD11c+ that cells expressed the
activation markers (B) CD40, (C) CD80, or (D) CD86. Results are representative of one experiment for transcriptomics and three independent experiments for flow
cytometry and show mean ± SEM. Statistical analysis was performed (A) using Cuffdiff (Eurofin) to determine the differential expression levels at the transcript level
including a measure of significance between samples. (B–D) one-way ANOVA with Bonferroni post-test was performed to determine significance (P < 0.05) where
*p < 0.05, **p < 0.001 and ***p < 0.0001 are significant compared to unstimulated.
signal values as well as fold- change values for this entire data
set are publicly available (Supplementary Table 5).
As expected, most transcripts scoring high in the pair wise
OPLS-DA analyses comparisons between control cells and
T. gondii co-cultured or LPS stimulated cells were immune
related or involved with signaling molecules/transcription
factors. Interestingly, many transcripts associated with energy
metabolism including glycolysis, TCA cycle and OXPHOS
as well as arginine metabolism were also ranked within the
initial 100 transcripts of interest (Supplementary Tables 1,
2). Similarly, multiple metabolites from these pathways
were highlighted within the first 50 metabolites of the
metabolome VIP tables and heatmaps (Supplementary Tables 3,
4 and Supplementary Figure 1). From both VIP tables,
it is clear that T. gondii induces metabolic changes
in BMDCs.
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FIGURE 3 | mRNA and protein levels of cytokines expressed by BMDCs when
co-cultured with T. gondii or stimulated with LPS. Bone marrow derived DCs
were either co-cultured with T. gondii or stimulated with LPS as indicated for 6
or 24 h. After 6 h, (A) mRNA was subsequently extracted and then quantified
using RNA-seq. Data shows the FPKM values. Red indicates an increase in
mRNA expression, green indicates a decrease in transcript expression and
gray shows no changes from the control cells. (B) A cytokine bead array was
performed on the supernatant to obtain cytokine protein levels. Results are
representative of one experiment for transcriptomics and three independent
experiments for flow cytometry and show mean ± SEM. Statistical analysis
was performed (A) using Cuffdiff (Eurofin) to determine the differential
expression levels at the transcript level including a measure of significance
between samples. (B) One-way ANOVA with Dunnett post-test. Significant
differences are p < 0.05 where * is compared to unstimulated.
Within this paper, only transcript and metabolic changes
associated with live T. gondii infection will be discussed
in great detail (Supplementary Figure 1). A limitation of
investigating the metabolic profile of BMDCs infected with
live parasites is distinguishing whether deviations of the
metabolites described herein are associated with changes
in BMDC function or reflect metabolites of the parasite.
In an attempt to understand the host contribution to the
observed metabolic changes in the absence of live parasites,
paraformaldehyde (PFA) fixed T. gondii or Toxoplasma lysate
antigen (TLA) were also used to stimulate BMDCs. Results
found either a marked reduction or only relatively minor
changes in cultures incubated with PFA fixed parasites
or TLA compared unstimulated BMDCs. This implies
that activation of parasite specific TLR receptors alone is
insufficient to modify the metabolism of BMDCs and that
an active infection is required (Supplementary Figure 1.7).
Consequently, we used both metabolomic data and
transcriptomic analysis in concert to gain insight into
the likely contribution of the host metabolism during
T. gondii infection.
T. gondii Infection Induces Aerobic
Glycolysis of BMDCs
Glycolysis is the first step in the breakdown of glucose
to produce the high-energy molecules, ATP and NADH.
Within this pathway, glucose is metabolized into pyruvate
(under aerobic conditions) or lactate (in an anaerobic
environment) (Figure 5A).
Distinct differences in glycolytic transcripts and metabolites
were observed in BMDCs following co-culture with T. gondii
or following LPS stimulation for 24 h. LCMS analysis detected
increased levels of the glycolytic metabolites, glucose, glucose 6
phosphate, fructose 6 phosphate, 2 phosphoglycerate, pyruvate
and lactate in BMDCs co-cultured with T. gondii compared
with control BMDCs (Figure 5B). These differences were
similar to those observed in LPS-stimulated BMDCs. Transcript
levels generally did not reflect this increase in glycolysis as
BMDCs co-cultured with T. gondii had decreased levels of
key transcripts encoding glycolytic enzymes phosphoglycerate
mutase (pgam2) and enolase (eno3). Transcription of genes
for the glucose transporters GLUT1 (slc2a1) and GLUT3
(slc2a3) was also reduced but there were modest increases
in monocarboxylate transporters MCT1 (slc16a1) and MCT6
(slc16a6) (Figure 5C). MCT1 is a proton dependent transporter
for lactate, pyruvate and ketone bodies (Fisel et al., 2018). MCT6
has the similar substrate specificity in vitro but its function
is unknown. BMDCs stimulated with LPS had significantly
increased levels of glucose transporters GLUT1, GLUT6 (slc2a1
and slc2a6), hexokinases (hk1, hk2, hk3), 6 phosphofructokinase
b3 (pfkfb3), lactate dehydrogenase a (ldha) and monocarboxylate
transporters MCT1 (slc16a1) and MCT10 (slc16a10). There were
significantly decreased levels of glucose transporters GLUT3,
GLUT8 and GLUT9 (slc2a3, slc2a8, slc2a9) glycolytic enzymes
glucose 6 phosphate isomerase (gpi), 6 phosphofructokinase
m (pfkm), aldolase c (aldoc), phosphoglycerate mutase (pgam)
and monocarboxylate transporters MCT6, MCT7, and MCT13
(slc16a6, slc16a7, and slc16a13) (Figure 5C). MCT10 is required
for transport of aromatic amino acids, GLUT9 has been
implicated in urate transport but the physiological roles of
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FIGURE 4 | Principal component analysis of BMDCs co-cultured with T. gondii or activated with LPS. Bone marrow derived DCs were co-cultured with T. gondii or
stimulated with LPS for 24 h. After this time, the metabolites of the DCs were extracted and run via Liquid chromatography mass spectroscopy (LCMS). The data was
then analyzed by SIMCA and a Principal component analysis plot was generated. Key: Blue, unstimulated; Green, LPS and Red, T. gondii.
GLUT6, GLUT8, MCT6, MCT7, and MCT13 have not been
determined (Cura and Carruthers, 2012; Fisel et al., 2018).
Overall, observed transcripts and metabolites associated with
glycolysis trend toward an induction of this pathway upon T.
gondii co-culture and LPS stimulation.
T. gondii Increases Glucose Uptake and
Up-Regulates LDH Activity in BMDCs
To further confirm the observed increase in glycolysis
highlighted in the transcriptomics and metabolomic
data, the ability of T. gondii to alter BMDC uptake of
2-NBDG (as a proxy for glucose) and influence lactate
dehydrogenase (LDH) activity was used. Co-culture of
BMDCs with T. gondii significantly increased glucose uptake
and elevated LDH activity compared with control BMDCs.
An increase in glucose uptake and up-regulation in LDH
activity was also observed in BMDCs stimulated with LPS
(Figures 6A,B). These findings confirm that upon T. gondii
infection, BMDCs increase their capability to take up glucose
favoring glycolysis.
T. gondii Infection Alters the TCA Cycle in
BMDCs
Once metabolized from pyruvate (the end product of glycolysis),
acetyl-CoA can enter the TCA cycle. The key reaction of
the cycle is the reduction of NAD+ into NADH, which can
then be introduced into the electron transport chain (i.e.,
OXPHOS) to generate ATP (Figure 7A). LCMS analysis from
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FIGURE 5 | Glycolysis differences in T. gondii co-cultured or LPS stimulated BMDCs. Bone marrow derived DCs were co-cultured with T. gondii or stimulated with
LPS as indicated for 6 or 24 h. After this time, the metabolites of the BMDCs were (B) extracted and analyzed by Liquid Chromatography Mass Spectroscopy (LCMS)
(Continued)
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FIGURE 5 | or (C) mRNA was extracted and then quantified using RNA-seq. Data shows the log2 (fold change) as normalized to unstimulated controls. Red indicates
an increase in transcript expression, green indicates a decrease in transcript expression and gray shows no changes from the control cells. For clarity, the diagram
shown in (A) focuses on relevant metabolites (shown in the graphs) and enzymes [depicted (a) through to (l)] for glycolysis only where (a) hexokinase; (b)
phosphoglucose isomerase; (c) phosphofructokinases; (d,e) aldolase; (f) triose phosphate isomerase; (g) glyceraldehyde 3 phosphate dehydrogenase; (h)
phosphoglycerate kinase; (i) phosphoglycerate mutase (j) enolase; (k) pyruvate kinase and (l) lactate dehydrogenase. Statistical analysis was either performed using
(B) a non-parametric Mann Whitney test, (C) Cuffdiff (Eurofin) to determine the differential expression levels at the transcript level including a measure of significance
between samples. Significant differences are p < 0.05 where * is compared to unstimulated. Results are representative of three independent runs.
FIGURE 6 | Glucose uptake and Lactate dehydrogenase activity were increased in BMDCs exposed to T. gondii. Bone marrow derived DCs were stimulated with LPS
or co-cultured with T. gondii (1:1 ratio). After 24 h (A) fluorescent 2-NBDG (50µM) was added for 120min. The mean fluorescent intensity (MFI) of 2-NBDG uptake in
BMDCs was then quantified using flow cytometry. (B) Supernatant from homogenized cells was used to calculated the LDH activity based on LDH reducing NAD to
NADH. Results are representative of three independent experiments (n = 3) and show the mean ± SEM. Statistical analysis performed using 1-way ANOVA with
Bonferroni post-test. Significant differences were identified where ***p < 0.001.
co-culturing T. gondii with BMDCs for 24 h demonstrated
increased levels of citrate and malate in T. gondii co-cultured
BMDCs (Figure 7B). A decrease in the majority of mRNA
transcripts in these cultures could be observed although only
succinate dehydrogenase B (sdhb) was statistically significant
in itself (Figure 7C). Similarly, many TCA intermediates were
up-regulated in LPS stimulated BMDCs including citrate,
alpha-ketoglutarate, fumarate and malate. Itaconate was
observed to be significantly down-regulated compared to naïve
cells (Figure 7B). Significant down-regulation of transcripts
for isocitrate dehydrogenase A, B and G (idh3g, idh3b, idha),
alpha ketoglutarate dehydrogenase (ogdh), succinate-coA
ligase (suclg1) and fumarate hydratase (fh) were evident
in LPS activated BMDCs in comparison to unstimulated
BMDCs. Significant upregulation of dihydrolipoamide S-
succinyltransferase (dlst) were observed in LPS stimulated
BMDCs (Figure 7C).
Transcripts for citrate synthase (cs) were upregulated in
LPS stimulated, but not T. gondii infected BMDCs. Similarly,
the citrate carrier (slc25a1) that transports citrate from the
mitochondria to the cytoplasm was markedly upregulated
in LPS stimulated BMDCs, but only modestly raised in
T. gondii infected BMDCs. Examination of potential routes
for citrate usage in the cytoplasm of LPS stimulated cells
revealed an increase in ATP citrate lyase (acly) which is
responsible for the conversion of citrate to acetyl coA.
However, transcripts for acetyl-CoA carboxylase (acaca) and
fatty acid synthase (fasn) which consecutively convert acetyl
coA to fatty acid were downregulated in these cells. In
contrast in T. gondii infected cells no change in ATP citrate
lyase (acly) transcripts were noticed, but an increase in
acetyl-CoA carboxylase (acaca) and fatty acid synthase (fasn)
were observed.
Generally, from our multi-omics data-set, we observed a
decrease in the majority of TCA transcripts, but an increase
in many metabolites associated with the TCA cycle. This
is in agreement with current metabolomic studies in LPS
stimulated macrophages and dendritic cells that show blockage
of specific TCA cycle enzymes leading to the increase of certain
intermediates. It has been shown that these metabolites have an
immunoregulatory role within host cell cells.
T. gondii Effects on the Electron Transport
Chain and Mitochondrial Membrane
Potential
Due to the direct link between the TCA cycle and electron
transport chain, the effect of T. gondii infection on transcripts
encoding components of the electron transport chain (ETC)
was assessed. Down regulation of components of the ETC was
observed in T. gondii infected and LPS stimulated BMDCs.
Generally, complex I (NADH dehydrogenase), complex II
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FIGURE 7 | TCA changes in T. gondii co-cultured or LPS stimulated BMDCs. Bone marrow derived DCs were co-cultured with T. gondii or stimulated with LPS as
indicated for 6 or 24 h. After this time, the metabolites of the BMDCs were (B) extracted and analyzed by Liquid Chromatography Mass Spectroscopy (LCMS) or
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 September 2019 | Volume 9 | Article 309
Hargrave et al. T. gondii Induced Metabolic Changes to DCs
FIGURE 7 | (C) mRNA was extracted and then quantified using RNA-seq. Data shows the log2(fold change) as normalized to unstimulated controls. Red indicates an
increase in transcript expression, green indicates a decrease in transcript expression and gray shows no changes from the control cells. For clarity, the diagram shown
in (A) focuses on relevant metabolites (shown in the graphs) and enzymes [depicted (a) through to (j)] for the TCA cycle only. (a) citrate synthase; (b) aconitase 2;
(c) isocitrate dehydrogenase 3; (d) alpha-ketoglutarate dehydrogenase; (e) succinyl-CoA synthetase; (f) succinate dehydrogenase; (g) fumarase; (h,i) malate
dehydrogenase; (j) cis-aconitate decarboxylase; (k) mitochondrial citrate carrier; (l) ATP citrate lyase; (m) acetyl CoA carboxylase; (n) fatty acid synthase;
(o) aconitase 1 and (p) isocitrate dehydrogenase 1. Statistical analysis was either performed using (B) a non-parametric Mann Whitney test, (C) Cuffdiff (Eurofin) to
determine the differential expression levels at the transcript level including a measure of significance between samples. Significant differences are p < 0.05 where * is
compared to unstimulated. Results are representative of three independent runs (n = 3).
(succinate dehydrogenase) and complex 3 (cytochrome bc1
complex) were unaffected or downregulated (of note, ndufa6
and sdhb were significantly (p<0.05) down-regulated). Previous
literature shows that a downregulation of the electron transport
chain is expected upon BMDC activation, as limiting ATP
production for energy allows TCAmetabolites to be used in other
biosynthetic pathways e.g., fatty acid biosynthesis. However,
interestingly, transcripts encoding subunits of complex IV and
V (ATP synthase) were generally found to be upregulated in
BMDCs following exposure to T. gondii. Statistically significantly
upregulated subunits were atp6v0b and atp2b4. This is a relatively
new concept with studies demonstrating that subunits IV
and V of the ETC have roles other than energy generation
including hemeA biosynthesis (cox11), transport of different ions
and maintenance of calcium homeostasis (atp2b4), mediating
acidification (atp6v0b) (Figure 8A).
Moreover, important differences in the mitochondrial
membrane potential (an indicator of oxidative phosphorylation)
between naïve and T. gondii-infected BMDCs were observed
using epifluorescence microscopy. After 24 h of co-culture
between BMDCs and T. gondii, Mitotracker Green was used
to stain mitochondria in combination with TMRM to visualize
mitochondrial membrane potential. TMRM accumulates in
active mitochondria with an intact membrane potential. A color
change from red/orange to yellow/green when Mitotracker
green and TMRM signals were merged demonstrates that
T. gondii and LPS reduce mitochondrial membrane potential
(Figures 8B–D). Furthermore, significant downregulation in
the relative mitochondrial membrane potential (TMRM/MTG)
mean per cell of T. gondii infected and LPS stimulated BMDCs
could be observed compared to naïve BMDCs (Figure 8E).
Overall, this indicates a decrease in oxidative phosphorylation in
T. gondii infected and LPS stimulated BMDCs.
T. gondii Infected BMDCs Direct Arginine
Metabolism to Polyamines and Proline
Independent of energy metabolism in T. gondii infected BMDCs,
RNA sequencing and LCMS analysis detected a number of
transcripts and metabolites associated with arginine metabolism
in T. gondii co-cultured BMDCs (Figure 9A). The metabolism
of arginine is associated with increased production of toxic
mediators deleterious to many pathogens. Notably, in T. gondii
infected BMDC cultures co-cultured for either 6 h (RNA) or 24 h
(metabolites), arginine levels were similar to control BMDCs and
only a small increase in citrulline levels was evident. However,
significant increases in L-ornithine, L-proline, L-1-pyrroline-
3-hydroxy-5-carboxylate and L-glutamate were observed in T.
gondii co-cultured BMDCs. This differed from LPS stimulation
which induced significantly increased levels of citrulline, N-
(omega)-hydroxyarginine and arginosuccinate as well as L-
proline and L-1-pyrroline-3-hydroxy-5-carboxylate (Figure 9B).
Transcripts for a number of enzymes involved in arginine
conversion to proline and glutamate were also seen to be
collectively augmented, but none other than spermidine synthase
(srm) were individually significantly increased in T. gondii
infected BMDC cultures (Figure 9C).
In keeping with the omics data, intracellular iNOS was
detected in 80% of CD11c+ BMDCs stimulated with LPS,
but in <10% of cells from T. gondii infected cultures.
Furthermore, nitrite levels in LPS stimulated, but not T. gondii-
infected BMDCs were significantly increased (Figures 10A,B).
Arginase enzyme activity was upregulated in BMDCs cultures
infected with T. gondii or stimulated with LPS. Collectively,
these observations support that arginine is primarily converted
to ornithine and polyamines in T. gondii infected cells
(Figure 11). In contrast, LPS stimulation primarily induces
arginine conversion to citrulline and recycling through N-
(L-arginosuccinate) with accompanying NO production. By
combining metabolomic, transcriptomic data with conventional
functional studies reveals that T. gondii is able to divert arginine
favorably toward ornithine and proline via arginase.
DISCUSSION
Previous studies using microarray analyses have examined global
changes in gene expression for human foreskin fibroblasts,
macrophages and DCs in response to T. gondii (Blader et al.,
2001; Chaussabel et al., 2003). These studies were conducted
before the development of RNASeq (which allows almost
complete coverage of the transcriptome) and non-targeted
metabolomic analyses LCMS techniques. The current studies
were initiated to make use of both these modern techniques
in concert with conventional functional studies to validate the
findings. We elected to use murine cells to complement and
enrich the datasets available and to allow extrapolation to the
many murine studies already published.
Recent studies have described how macrophages and to some
extent BMDCs undergo metabolic changes when exposed to
environmental stimuli. Generally, LPS stimulation culminates
in a shift from oxidative phosphorylation to aerobic glycolysis,
whereas augmented oxidative phosphorylation and ATP
production occurs in those stimulated with IL-4 (Newsholme
et al., 1986; Jantsch et al., 2008; Rubic et al., 2008; Krawczyk et al.,
2010; Infantino et al., 2011; Everts et al., 2012; O’Neill andHardie,
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FIGURE 8 | T. gondii infection and LPS activation decreases mitochondria membrane potential within BMDCs. Bone marrow derived DCs were co-cultured with T.
gondii (1:1 ratio) or activated with LPS. (A) After 6 h, mRNA was subsequently extracted and then quantified using RNA-seq. Data shows the Log2(fold change) as
(Continued)
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FIGURE 8 | normalized to unstimulated controls. Red indicates an increase in transcript expression, green indicates a decrease in transcript expression and gray
shows no change from control cells. For Clarity, relevant gene abbreviates are shown in the diagram where Complex I is NADH dehydrogenase (ndufs1-bdufb6),
Complex II is Succinate dehydrogenase (sdhc-sdha), Complex III is Cytochrome bc1 complex (uqcrc1-uqcrfs1), Complex IV is Cytochrome C oxidase (cox7b–cox15)
and Complex V is ATP synthase (Atp6ap2–atp5k). Statistical analysis was performed using Cuffdiff (Eurofin) to determine the differential expression levels at the
transcript including a measure of significance between samples. (B–D) After 24 h, the cells were stained with 100 nM of Mitotracker Green and 100 nM TMRM for
30min to determine mitochondrial morphology. The images show separate images for Bright field (BF), Mitotracker green (MtG), TMRM and then MtG and TMRM
merged (TMRM/MTG). Examples of areas used for quantification of relative mitochondrial potential are shown zoomed in yellow dashed boxes. Images are
representative of at least 3 independent runs per group, with excitation light intensity and image intensity kept constant throughout. (E) Relative mitochondrial
membrane potential for control BMDCs, BMDCs stimulated with LPS or BMDCs infected with T. gondii (determined as described in the material and methods
section). Statistical analysis performed using non-parametric Kruskal-Wallace ANOVA with Dunn’s post-hoc test (OriginPro), with ***p < 0.001; individual cell values
overlaid with median ± 95% confidence interval.
2013; Tannahill et al., 2013; Jha et al., 2015; O’Neill and Pearce,
2016). However, the effect of intracellular pathogens on cellular
metabolism is less well-studied and indeed more complex as host
cells undergo metabolic changes that have evolved to directly kill
pathogens or restrict access to essential nutrients (Denkers, 2010;
Pifer and Yarovinsky, 2011). Conversely pathogens have evolved
mechanisms to subvert host cell metabolism for their own
benefit. As these early events are important for establishment of
infection, initiating host immunity and determining the eventual
success of infection we have employed a multi-omics approach
to inform confirmatory functional assays.
Initial studies determined that using the procedures outlined,
a T. gondii infection rate of approximately 80% could be achieved
in BMDCs with concurrent upregulation of costimulatory
molecules (CD40, CD80, and CD86) and their transcripts cd80
and cd86. A similar pattern of changes was also observed
by BMDCs stimulated with LPS. This is consistent with the
literature (Verhasselt et al., 1997; Morgado et al., 2014). In
keeping with the literature that demonstrates the ability of
T. gondii infection to inhibit MHCI and II expression in
macrophages, the majority of MHC Class I and II transcripts
were down-regulated in T. gondii co-cultured BMDCs (Lüder
et al., 2001). In contrast, LPS stimulated BMDCs had elevated
levels of many transcripts associated with MHC I and II
complex. Additionally, T. gondii infected BMDCs had congruent
elevated expression of both mRNA and protein levels of pro-
inflammatory cytokines IL-1α, IL-12, and IL-6 (Nam et al.,
2011). These data validate the model of infection and the multi-
omics approach where metabolomic, transcriptomic data and
functional studies can complement, be related to, and add value
to each other.
Principal component analysis and Orthogonal projection
to latent structure for discriminant analyses (OPLS-DA)
was used to determine the major changes identified through
RNA sequencing and non-targeted liquid chromatography
mass spectroscopy (LCMS). From the VIP tables generated
from our OPLS-DA analysis, metabolites associated
with energy metabolism including glycolysis, the TCA
cycle and oxidative phosphorylation were determined
as major discriminants (i.e., the first 100 transcripts/
metabolites) between control uninfected and T. gondii
infected cells.
Glycolysis is metabolic pathway that converts glucose into
pyruvate. The energy released in this process is used by
downstream metabolic processes to form ATP and NADH.
From transcriptomic and metabolic analyses, T. gondii co-
cultured with BMDCs for 24 h demonstrated an increase
in glycolysis intermediates (glucose 6 phosphate, fructose 6
phosphate, 2 phosphoglycerate, pyruvate and lactate) when
compared with control BMDCs. Our results also found that LPS
stimulation of dendritic cells had a similar effect on glycolysis
intermediates. In keeping with these results, we noted increased
levels of transcripts for some glycolytic enzymes including hk
and pfkfb3, the highly active isoform of phosphofructokinase.
We noted a reduction in phosphoenolpyruvate in infected
cultures, which could be linked to the downregulation of Eno3
or alternatively due to parasite utilization of this resource.
Similarly, up-regulation of ACCase and FAS may allow T.
gondii to take advantage of the increased production of
pyruvate and acetyl-CoA from TCA intermediates that is
then used to increase glycolytic demand or FA synthesis (in
the apicoplast of the parasite). Conversely, the parasite could
contribute to the observed increase in pyruvate we report
in infected cultures. Thus, T. gondii has the opportunity to
contribute to metabolites measured and to exploit host cell
resources. Again, LPS stimulated BMDCs underwent similar,
but more profound changes to their transcripts encoding
glycolytic intermediates.
Through functional assays we were able to demonstrate that
even though T. gondii infected BMDC had reduced transcript
expression of the glucose transporter GLUT1 (slc2a1), they had
increased uptake of 2-NBDG as a surrogate for glucose and
had increased levels of LDH activity compared with control
BMDCs. This apparent discrepancy could be due to temporal
differences in RNA expression and GLUT1 activity or reflect
increased efficiency of transport of glucose due to increased
utilization, recruitment of intracellular sugar transporters to
the plasma membrane or activation of GLUT1 by reduction
in ATP levels (Cura and Carruthers, 2012). Increased levels
of lactate and LDH activity was accompanied by increased
expression of MCT1, a protein responsible for lactate eﬄux
required to prevent intracellular acidification (Fisel et al., 2018).
Interestingly, LDH activity also correlates with an increase
metabolites (3-(4- hydroxyphenyl) lactate and indolelactate)
produced by LDH from products of aromatic amino acid
catabolism. Collectively, these results demonstrate that both T.
gondii infection of BMDCs and LPS stimulation of BMDCs
increase glucose uptake, glycolysis and lactate production in
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FIGURE 9 | Arginine metabolism changes in BMDCs co-cultured with T. gondii or stimulated with LPS. Bone marrow derived DCs were co-cultured with T. gondii or
stimulated with LPS as indicated for 6 or 24 h. After this time, the metabolites of the BMDCs were (B) extracted and analyzed by Liquid Chromatography Mass
(Continued)
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FIGURE 9 | Spectroscopy (LCMS) or (C) mRNA was extracted and then quantified using RNA-seq. Data shows the log2(fold change) as normalized to unstimulated
controls. Red indicates an increase in transcript expression, green indicates a decrease in transcript expression and gray shows no changes from the control cells. For
clarity, the diagram shown in (A) focuses on relevant metabolites (shown in the graphs) and enzymes [depicted (a) through to (h)] for arginine metabolism only:
(a) NOS; (b) argininosuccinate synthase; (c) argininosuccinate lyase; (d) arginase; (e) ornithine decarboxylase; (f) ornithine aminotransferase; (g) spermidine
synthase; (h) spermine synthase; and (i) △1-pyrroline- 5-carboxylate reductase. Statistical analysis was performed using (B) non-parametric Mann Whitney test,
(C) Cuffdiff (Eurofin) to determine the differential expression levels at the transcript including a measure of significance between samples. Significant differences are p
< 0.05 where * is compared to unstimulated. Results are representative of three independent runs (n = 3).
FIGURE 10 | Intracellular iNOS expression and NO production is not altered in BMDCs infected with T. gondii. Bone marrow derived DCs were co-cultured with
T. gondii (1:1 ratio) or stimulated with LPS. After 24 h, (A) CD11c+ cells were analyzed for iNOS expression by flow cytometry. (B) supernatants were used to measure
NO by Griess assay. Results are representative of three independent experiments and show the mean ± SEM. Statistical analysis performed using 1-way ANOVA with
Bonferroni post-test. Significant differences were identified where ***p < 0.001.
cells even under normoxic conditions, a phenomenon sometimes
referred to as aerobic glycolysis or the Warburg effect (Warburg
et al., 1958; Reviewed by Rodríguez-Prados et al., 2010; Kelly and
O’Neill, 2015).
The Warburg effect is not only associated with aerobic
glycolysis, but also by a down-regulation of the TCA cycle
and this has already been reported in macrophages stimulated
with LPS (Jha et al., 2015). The majority of mRNA transcripts
associated with the TCA cycle were down-regulated in LPS
activated and T. gondii infected BMDCs compared to naïve
BMDCs. As a predicted physiological consequence of such
circumstances we also detected increased levels of many TCA
intermediates in T. gondii infected BMDCs and LPS stimulated
BMDCs including citrate and malate. In the literature, a build-
up of specific TCA intermediates and reduction in TCA cycle
for ATP production has been reported in LPS stimulated
macrophages. It has been suggested that this facilitates a variety
of biosynthetic processes that depend on these intermediates
(O’Neill, 2011; Tannahill et al., 2013; Lampropoulou et al., 2016;
Mills et al., 2016). For example, citrate itaconic accumulates
due to breaks in the TCA cycle between the isocitrate and
alpha-ketoglutarate conversion step (catalyzed by isocitrate
dehydrogenase) (Infantino et al., 2013; Jha et al., 2015). Citrate
can also be replenished by the anaplerotic reactions of the TCA
cycle (conversion of aspartate into oxaloacetate by aspartate
aminotransferase). Export of citrate by the mitochondrial citrate
carrier is accompanied by uptake of malate from the cytoplasm
(converted to citrate by enzymes of the TCA cycle). In
support of this possibility, a marked increase in transcripts
for the citrate carrier was noted in LPS stimulated BMDCs.
Furthermore, studies of macrophages demonstrate that LPS
stimulation increased expression of the citrate carrier which
increased cytosolic citrate levels which through the action of
citrate lyase produces acetyl CoA and oxaloacetate. Oxoalocetate
is converted to malate via malate dehydrogenase then pyruvate
to generate NADPH required for ROS and NO production.
Using gene silencing to ablate the citrate carrier gene in this
system was therefore found to reduce NO and ROS production
(Infantino et al., 2011). The concurrently generated aceyl-CoA
can augment fatty acid synthesis (Everts et al., 2012; O’Neill
and Pearce, 2016). Consequently, these changes to energy
metabolism with accompanying biosynthetic reprogramming
are likely to have a widespread influence on proximal and
distal immune cell function including cytokine production and
membrane remodeling. We suggest that these changes, similar
to those seen following LPS stimulation (in the absence of
infection) are host evolved mechanisms that occur during T.
gondii infection are likely to provide host benefits in terms
of shaping the immune response but can potentially aid
parasite growth.
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FIGURE 11 | BMDCs up-regulate Arginase-1 activity in response to T. gondii.
Bone marrow derived DCs were co-cultured with T. gondii (1:1 ratio) or
stimulated with LPS. After 24 h, Urea (µg/ml) was measured from
homogenized cells. This is indicator of Arginase-1 activity. Results are
representative of three independent experiments (n = 3) and show the mean ±
SEM. Statistical analysis performed using 1-way ANOVA with Bonferroni
post-test. Significant differences were identified where ***p < 0.001.
As the TCA cycle is linked to the ETC in mitochondria we
examined the effect of T. gondii infection on transcripts for
components of the ETC. We found that a number of these
transcripts encoding complex I, II and III were down regulated
in T. gondii infected BMDCs and LPS stimulated BMDCs.
However, transcripts encoding complex IV and V subunits
were increased in BMDCs infected T. gondii or stimulated
with LPS. It has been observed in the literature that specific
components of the ETC have additional roles other than
generating energy including heme A biosynthesis, ion transport,
calcium homeostasis, vesicle formation and lipid signaling
(Antonicka et al., 2003; Sharma et al., 2019). Interestingly, there
was an increase in gamma-glutamyl cysteine and cystine but
not glutathione. These results suggest a response to oxidative
stress (e.g., increased cysteine and glutathione synthesis to
maintain intracellular glutathione levels. Additionally, to further
determine the functional implications of these transcriptional
changes we exploited the membrane potential-sensitive dye,
TMRM. Our results indicate that mitochondria membrane
potential is similarly down regulated in BMDCs infected with
T. gondii or stimulated with LPS (Zhu et al., 2015; Van
den Bossche et al., 2016). This is likely due to a reduced
TCA cycle.
Changes to arginine metabolism in T. gondii infected BMDCs
were also clearly evident in these studies described. Notably
T. gondii infection favored the expression of arginase and
production of L-ornithine, L-proline, L-1-pyrroline-3-hydroxy-
5-carboxylate, and L-glutamate. Concomitant increases in the
levels of transcript for srm which encodes spermidine synthesis
was elevated in these infected cells suggesting further metabolism
of ornthine to polyamines. In contrast LPS activation of
BMDCs favored the expression of iNOS and the production
of nitric oxide and citrulline. Opposing hypotheses can be
formed as to whether these changes benefit the host or the
parasite. Viewing the alteration in arginine metabolism as a
host evolved strategy, arginine depletion has the potential to
restrict T. gondii growth as it is an arginine auxotroph (Fox
et al., 2004). Alternatively, directing arginine metabolism toward
ornithine, proline and polyamines can also be viewed as a
parasite evolved strategy subverting arginine metabolism toward
arginase degradation reducing the ability of iNOS to produce
nitric oxide which has been shown to have limit parasite
multiplication. Additionally, diverting arginine toward ornithine
and polyamines and ultimately to glutamate may provide T.
gondii this resource for downstream use in the TCA cycle.
In support of this studies have demonstrated that ROP16
(released from the rhoptry organelles during invasion) induces
Arg expression in a STAT6 dependent manner (El Kasmi et al.,
2008; Butcher et al., 2011; Marshall et al., 2011). In reality,
as parasites and hosts evolve together both these hypotheses
can coexist. Importantly, our previously published work
demonstrates that T. gondii growth can be curtailed in vivo both
through arginase dependent and iNOS dependent mechanisms
(Woods et al., 2013).
Overall the studies described herein, demonstrate that
the metabolism of BMDCs are profoundly affected by T.
gondii infection in a manner similar to the Warburg effect.
The multi-omics approach used here provides a wealth of
metabolic and transcriptomic indicators of other pathways
that are affected including arginine metabolism and provide
insight in to the potential interactions of the host and
parasite biochemistry. Understanding the interplay of these
host and parasite interactions could provide insight into novel
antimicrobial therapies including host directed interventions to
limit parasite multiplication and survival.
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